These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 30847369)
1. In vivo evidence for pre-symptomatic neuroinflammation in a MAPT mutation carrier. Bevan-Jones WR; Cope TE; Jones PS; Passamonti L; Hong YT; Fryer T; Arnold R; Coles JP; Aigbirhio FI; O'Brien JT; Rowe JB Ann Clin Transl Neurol; 2019 Feb; 6(2):373-378. PubMed ID: 30847369 [TBL] [Abstract][Full Text] [Related]
3. [ Wolters EE; Papma JM; Verfaillie SCJ; Visser D; Weltings E; Groot C; van der Ende EL; Giannini LAA; Tuncel H; Timmers T; Boellaard R; Yaqub M; van Assema DME; Kuijper DA; Segbers M; Rozemuller AJM; Barkhof F; Windhorst AD; van der Flier WM; Pijnenburg YAL; Scheltens P; van Berckel BNM; van Swieten JC; Ossenkoppele R; Seelaar H Neurology; 2021 Sep; 97(10):e1017-e1030. PubMed ID: 34210823 [TBL] [Abstract][Full Text] [Related]
4. Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Ghetti B; Oblak AL; Boeve BF; Johnson KA; Dickerson BC; Goedert M Neuropathol Appl Neurobiol; 2015 Feb; 41(1):24-46. PubMed ID: 25556536 [TBL] [Abstract][Full Text] [Related]
5. Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features. Ikeda A; Shimada H; Nishioka K; Takanashi M; Hayashida A; Li Y; Yoshino H; Funayama M; Ueno Y; Hatano T; Sahara N; Suhara T; Higuchi M; Hattori N Mov Disord; 2019 Apr; 34(4):568-574. PubMed ID: 30773680 [TBL] [Abstract][Full Text] [Related]
6. Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation. Su Y; Fu J; Yu J; Zhao Q; Guan Y; Zuo C; Li M; Tan H; Cheng X J Alzheimers Dis; 2020; 76(1):149-157. PubMed ID: 32444551 [TBL] [Abstract][Full Text] [Related]
8. 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers. Smith R; Puschmann A; Schöll M; Ohlsson T; van Swieten J; Honer M; Englund E; Hansson O Brain; 2016 Sep; 139(Pt 9):2372-9. PubMed ID: 27357347 [TBL] [Abstract][Full Text] [Related]
9. In Vivo Zhou XY; Lu JY; Liu FT; Wu P; Zhao J; Ju ZZ; Tang YL; Shi QY; Lin HM; Wu JJ; Yen TC; Zuo CT; Sun YM; Wang J Mov Disord; 2022 Mar; 37(3):525-534. PubMed ID: 34842301 [TBL] [Abstract][Full Text] [Related]
10. Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study. Dopper EG; Chalos V; Ghariq E; den Heijer T; Hafkemeijer A; Jiskoot LC; de Koning I; Seelaar H; van Minkelen R; van Osch MJ; Rombouts SA; van Swieten JC Neuroimage Clin; 2016; 12():460-5. PubMed ID: 27625986 [TBL] [Abstract][Full Text] [Related]
11. Long-Term Hydromethylthionine Treatment Is Associated with Delayed Clinical Onset and Slowing of Cerebral Atrophy in a Pre-Symptomatic P301S MAPT Mutation Carrier. Bentham P; Staff RT; Schelter BO; Shiells H; Harrington CR; Wischik CM J Alzheimers Dis; 2021; 83(3):1017-1023. PubMed ID: 34366349 [TBL] [Abstract][Full Text] [Related]
12. In vivo detection of neuropathologic changes in presymptomatic MAPT mutation carriers: a PET and MRI study. Miyoshi M; Shinotoh H; Wszolek ZK; Strongosky AJ; Shimada H; Arakawa R; Higuchi M; Ikoma Y; Yasuno F; Fukushi K; Irie T; Ito H; Suhara T Parkinsonism Relat Disord; 2010 Jul; 16(6):404-8. PubMed ID: 20452812 [TBL] [Abstract][Full Text] [Related]
13. Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images. Whitwell JL; Boeve BF; Weigand SD; Senjem ML; Gunter JL; Baker MC; DeJesus-Hernandez M; Knopman DS; Wszolek ZK; Petersen RC; Rademakers R; Jack CR; Josephs KA Eur J Neurol; 2015 May; 22(5):745-52. PubMed ID: 25683866 [TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cells (iPSCs) derived from a pre-symptomatic carrier of a R406W mutation in microtubule-associated protein tau (MAPT) causing frontotemporal dementia. Rasmussen MA; Hjermind LE; Hasholt LF; Waldemar G; Nielsen JE; Clausen C; Hyttel P; Holst B Stem Cell Res; 2016 Jan; 16(1):105-9. PubMed ID: 27345791 [TBL] [Abstract][Full Text] [Related]
16. Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales. Fumagalli GG; Basilico P; Arighi A; Bocchetta M; Dick KM; Cash DM; Harding S; Mercurio M; Fenoglio C; Pietroboni AM; Ghezzi L; van Swieten J; Borroni B; de Mendonça A; Masellis M; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni GB; Laforce R; Finger E; Sorbi S; Scarpini E; Rohrer JD; Galimberti D; Alzheimers Res Ther; 2018 May; 10(1):46. PubMed ID: 29793546 [TBL] [Abstract][Full Text] [Related]
17. Rapidly Progressive Frontotemporal Dementia Associated with MAPT Mutation G389R. Sun L; Chen K; Li X; Xiao S J Alzheimers Dis; 2017; 55(2):777-785. PubMed ID: 27802239 [TBL] [Abstract][Full Text] [Related]
18. A Peculiar Tau Accumulation Pattern Identified Via 18 F-Florzolotau PET Imaging in a Patient With Frontotemporal Dementia Caused by a Mutation in the MAPT Gene. Li Q; Li H; Huang Z; Li Y; Cui R Clin Nucl Med; 2024 Oct; 49(10):995-996. PubMed ID: 39010313 [TBL] [Abstract][Full Text] [Related]
19. de novo MAPT mutation G335A causes severe brain atrophy, 3R and 4R PHF-tau pathology and early onset frontotemporal dementia. Ando K; Ferlini L; Suain V; Yilmaz Z; Mansour S; Le Ber I; Bouchard C; Leroy K; Durr A; Clot F; Sarazin M; Bier JC; Brion JP Acta Neuropathol Commun; 2020 Jun; 8(1):94. PubMed ID: 32600421 [No Abstract] [Full Text] [Related]
20. MAPT Q336H mutation: Intrafamilial phenotypic heterogeneity in a new Italian family. Villa C; Rossi G; Bizzozero I; Prioni S; Boiocchi C; Agosta F; Canu E; Filippi M; Giaccone G; Caroppo P Eur J Neurol; 2022 May; 29(5):1529-1533. PubMed ID: 35020237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]